Kornitzer Capital Management Inc. KS Decreases Stock Position in Encompass Health Co. (NYSE:EHC)

Kornitzer Capital Management Inc. Encompass Health Co. in the third quarter, according to the KS company’s latest 13F filing with the SEC. (NYSE:EHC – Get Rating ) reduced its holdings by 58.1%. The institutional investor owned 36,157 shares of the company’s stock after selling 50,130 shares during the period. Kornitzer Capital Management Inc. KS’s holdings in Encompass Health were worth $1,635,000 as of its most recent SEC filing.

→ “We need batteries. Literally everywhere.” (Based on investment trends)

A number of other institutional investors and hedge funds have also modified their holdings of EHC. Sei Investments Co. raised its position in Encompass Health by 29.4% in the 2nd quarter. Sei Investments Co. now owns 213,253 shares of the company’s stock worth $12,010,000 after buying an additional 48,456 shares in the last quarter. have Mackenzie Financial Corp bought a new stake in Encompass Health in the 2nd quarter worth approximately $289,000. Mitsubishi UFJ Trust & Banking Corp raised its stake in Encompass Health by 12.4% in the 2nd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 8,996 shares of the company’s stock valued at $504,000 after purchasing an additional 995 shares during the period. Aptus Capital Advisors LLC purchased a new position in shares of Encompass Health during the 3rd quarter valued at $1,788,000. Finally, 1492 Capital Management LLC bought a new stake in Encompass Health in the second quarter valued at $221,000. Institutional investors own 96.14% of the company’s shares.

Also Read :  Scientists think covid might trigger diabetes in children

Wall Street analysts forecast growth

A number of equities research analysts have issued reports on EHC shares. StockNews.com began coverage on Encompass Health in a research note on Wednesday, October 12th. They assign a “hold” rating to the company. Stephens reduced their target price on shares of Encompass Health from $60.00 to $58.00 and set an “overweight” rating for the company in a report on Friday, October 28th. TheStreet upgraded shares of Encompass Health from a “c+” rating to a “b-” rating in a research note on Wednesday, December 21st. Finally, Raymond James boosted their price objective on shares of Encompass Health from $65.00 to $72.00 and gave the company a “strong-buy” rating in a research report on Friday, October 28th. One equities research analyst has rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $64.13, based on data from MarketBeat.

Insiders bet

In related news, Director Greg D. Carmichael acquired 1,830 shares of the stock in a transaction dated Monday, October 31st. The shares were acquired at an average cost of $54.67 per share for a total value of $100,046.10. Following the purchase, the director now directly owns 10,546 shares in the company, valued at $576,549.82. The transaction was disclosed in a document filed with the Securities and Exchange Commission, which can be accessed via this hyperlink. 2.70% of the shares are currently owned by insiders.

Also Read :  Food truck health standards: How clean are they?

Include health shares up to 0.7%

Shares of EHC opened at $62.68 on Monday. Encompass Health Co. has a 12-month low of $44.33 and a 12-month high of $74.61. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 1.59. The company has a market capitalization of $6.25 billion, a PE ratio of 23.04, a price-to-earnings-growth ratio of 2.64 and a beta of 1.02. The business has a 50-day moving average of $58.43 and a 200-day moving average of $53.25.

Encompass Health (NYSE:EHC – Get Rating ) last issued its quarterly earnings data on Wednesday, October 26th. The company reported $0.67 EPS for the quarter, missing the consensus estimate of $0.68 by ($0.01). The business had revenue of $1.09 billion for the quarter, compared to the consensus estimate of $1.06 billion. Encompass Health had a net margin of 5.39% and a return on equity of 15.59%. research analysts expect that Encompass Health Co. will post . Earnings of 2.79 per share will be given.

Enter health profile

(Get Rating)

Encompass Health Corp. Engaged in providing post-acute healthcare services. It operates through inpatient rehabilitation and home health and hospice divisions. The Inpatient Rehabilitation Division operates inpatient rehabilitation hospitals that provide rehabilitation treatment and care to patients recovering from stroke and other neurological disorders, heart and lung conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Also Read :  Hims & Hers Health, Inc. (NYSE:HIMS) Given Consensus Rating of "Hold" by Brokerages

Further reading

Want to see what other hedge funds EHC has? Encompass Health Co. (NYSE:EHC – Rated Receive) Visit HoldingsChannel.com to get the latest 13F filings and insider trades.

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

These instant news alerts are generated using anecdotal technology and MarketBeat’s financial data to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Before you consider Encompass Health, you’ll want to ask this.

MarketBeat tracks Wall Street’s top-rated and best-performing research analysts and the stocks they recommend to their clients daily. MarketBeat has identified five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on … and Encompass Health wasn’t on the list.

Encompass Health currently has a “Buy” rating among analysts, and the top rated analysts believe these five stocks are better buys.

Check out the five parts here

Elon Musk’s next move

Wondering when you’ll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to know when Elon Musk will finally allow these companies to IPO.

Get this free report

Elon Musk's next move is the cover


Leave a Reply

Your email address will not be published.